Search for: "Sandoz Pharmaceuticals Corporation"
Results 1 - 20
of 82
Sorted by Relevance
|
Sort by Date
7 Sep 2009, 9:34 pm
Sandoz Inc. 2:09-cv-04513; filed September 1, 2009 in the District Court of New Jersey • Plaintiffs: King Pharmaceuticals Inc.; King Pharmaceuticals Research and Development, Inc.; Elan Corporation, PLC.; Elan Pharma International Ltd. [read post]
6 Oct 2021, 10:12 am
Generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, will pay $447.2 million to settle allegations that they conspired to artificially inflate the price of multiple generic drugs. [read post]
Parmaceutical Companies pay over $400 million to settle allegations of price fixing of generic drugs
1 Oct 2021, 9:28 am
Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, have agreed to pay a total of $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
9 Oct 2009, 9:11 am
Sandoz Inc. [read post]
1 Dec 2009, 9:45 am
Sandoz Inc. [read post]
21 Dec 2010, 11:00 am
(“Sandoz”) requests from the Agency a written decision that Cobrek Pharmaceuticals, Inc. [read post]
17 Feb 2010, 8:00 am
Sandoz Inc. [read post]
5 Nov 2021, 5:21 pm
Department of Justice press release states, in part: Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, have agreed to pay a total of $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
5 Nov 2021, 5:21 pm
Department of Justice press release states, in part: Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc. and Apotex Corporation, have agreed to pay a total of $447.2 million to resolve alleged violations of the False Claims Act arising from conspiracies to fix the price of various generic drugs. [read post]
1 Apr 2014, 4:52 am
After issuing orders, the Court heard oral arguments in Alice Corporation v. [read post]
18 Nov 2008, 10:40 pm
In separate development, Orion Corporation has filed a patent lawsuit (in the US District Court for the District of New Jersey) against Sun Pharmaceutical Industries Limited for alleged infringement of OB listed US Patent No. 5,446,194 (the ‘194 patent) for Stalevo, a combination drug (carbidopa, levodopa and entacapone) for the treatment of Parkinson disease. [read post]
28 Aug 2009, 8:11 am
Sandoz International GmbH and Sandoz Inc. [read post]
4 Sep 2012, 7:38 am
Sandoz, Inc., 678 F.3d 1280 (Fed. [read post]
17 Oct 2014, 7:23 am
At Bloomberg View, Noah Feldman analyzes Wednesday’s oral argument in the patent case Teva Pharmaceuticals USA v. [read post]
2 Feb 2009, 9:51 am
This January 2008 press release from KV Pharmaceutical, the parent company of ETHEX, includes a list of the more than 60 generic drugs being recalled by ETHEX. [read post]
23 Jul 2018, 12:05 pm
Teva Pharmaceuticals USA, Inc., et al., No. 17-1229. [read post]
23 Aug 2016, 9:41 am
Neil Wilkof ponders the legacy of brands following a corporate split or acquisition. [read post]
2 Mar 2007, 9:06 am
At the March 6 annual meeting of Swiss pharmaceutical giant Novartis, chairman and CEO Daniel Vasella and Hans-Joerg Rudloff, chair of the compensation committee, are up for reelection. [read post]
2 Dec 2009, 4:31 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Venezuela to examine all pharmaceutical patents (IP tango) General World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Biodiversity negotiations need to allow for flexibility in business, industry says (IP Watch) Brazilian government tailors a bill… [read post]
28 Oct 2010, 10:14 am
” Then there’s a recent quarterly report that Caraco Pharmaceutical Laboratories, Ltd. [read post]
